期刊文献+

影响腹膜透析患者血红蛋白水平达标的相关因素分析 被引量:5

Analysis of the factors influencing the targeted hemoglobin level in peritoneal dialysis patients
下载PDF
导出
摘要 目的分析影响腹膜透析(peritoneal dialysis,PD)患者血红蛋白(hemoglobin,Hb)达标的相关因素。方法分析2003年5月1日至2015年10月31日宁夏医科大学总医院随访1年及以上的PD患者临床资料。按研究结束时Hb水平将患者分为达标组(Hb≥110g/L)和未达标组(Hb<110g/L),根据贫血分级标准将未达标组分为轻度贫血(90g/L≤Hb<110g/L)和中重度贫血组(Hb<90g/L);比较达标组与未达标组及未达标组不同程度贫血患者临床特征,分析影响Hb未达标的相关因素。结果①共纳入267例PD患者,男性59.93%,平均年龄52岁,中位透析龄37(21,61)月。基线Hb(80.16±14.89)g/L,研究结束时Hb达标率为50.30%。②与达标组比较,Hb未达标组患者年龄、肾小球滤过率、基线Hb水平、Kt/V、红细胞生成素使用量低,透析龄、全段甲状旁腺激素(intact parathormone,iPTH)高(t/Z值分别为2.894,4.400,6.833,3.992,1.396,-3.757,2.364;P值分别为0.004,<0.001,<0.001,<0.001,0.041,<0.001,0.019);③轻度贫血组较Hb达标组患者年龄、基线Hb水平、残余肾小球滤过率、Kt/V及红细胞生成素使用量低,透析龄、iPTH高(t/Z值分别为2.021,6.193,2.515,3.729,-2.336,-2.768,-2.312;P值分别为0.044,<0.001,0.013,<0.001,0.019,0.006,0.021);④Logistic回归分析提示女性、年龄轻、透析不充分、低蛋白血症是Hb不达标的独立危险因素(OR值分别为0.416,1.019,0.285,0.942;P值分别为0.021,0.003,<0.001,0.027)。结论女性、年龄轻、透析不充分及低蛋白血症是Hb不达标的独立危险因素。 Objective To investigate the risk factors influencing peritoneal dialysis(PD)patients to reach the target hemoglobin(Hb)level.Methods PD patients treated in the General Hospital of Ningxia Medical University during the period from May 2003 to October 2015 and followed up for more than one year were retrospectively analyzed.Based on the Hb level at the end of follow-up period,they were divided into targeted group(Hb≥110g/L)and non-targeted group(Hb<110g/L);patients in the non-targeted group were further divided into mild anemia subgroup(90g/L≤Hb<110g/L)and moderate or severe anemia subgroup(Hb<90 g/L).The risk factors influencing peritoneal dialysis(PD)patients to reach the target Hb level were obtained through the comparison of clinical characteristics between targeted group and non-targeted group and between the two subgroups.Results①A total of 267 PD patients were enrolled in this study.In this cohort of PD patients,59.93%were males,the mean age was 52 years old,the median PD vintage was 37 months,the mean follow-up period was 37(21,61)months,the baseline mean Hb level was 80.16±14.89g/L,and 50.30%of the patients reached the targeted Hb level.②Patients in non-targeted group had younger age,longer PD vintage,lower rGFR,lower baseline Hb level,higher iPTH level,lower Kt/V and lower erythropoietin dose,as compared with those in the patients in targeted group(t/Z=2.894,-3.757,4.400,6.833,2.364,3.992 and 1.396 respectively;P=0.004,<0.001,<0.001,<0.001,0.019,<0.001 and 0.041 respectively).③Patients in mild anemia subgroup had younger age,longer PD vintage,lower baseline Hb level,rGFR,Kt/V and erythropoietin dose,and higher iPTH as compared with those in the patients in targeted group(t/Z=2.021,-2.768,6.193,2.515,3.729,-2.336 and-2.312 respectively;P=0.044,0.006,<0.001,0.013,<0.001,0.019 and 0.021 respectively);similar results could also be found when the comparisons were made between moderate or severe anemia subgroup and targeted group.④Multivariate logistic regression analysis showed that female(OR=0.416,P=0.021),younger age(OR=1.019,P=0.003),inadequate dialysis(OR=0.285,P<0.001)and hypoalbuminemia(OR=0.942,P=0.027)were the independent risk factors for unable to reach the target Hb level.Conclusions Female,younger age,inadequate dialysis and hypoalbuminemia were the independent risk factors for failure to reach the target Hb level.
作者 田延红 田娜 张倩 王艳 马小琴 王丽 徐梅 张红霞 陈孟华 TIAN Yan-hong;TIAN Na;ZHANG Qian;WANG Yan;MA Xiao-qin;WANG Li;XU Mei;ZHANG Hongxia;CHEN Meng-hua(Department of Nephrology,General Hospital of Ningxia Medical University,Ningxia Clinical Research Center for Kidney Disease,Yinchuan 750004,China;Department of Nephrology,Central Hospital of Yuncheng,Yuncheng 044000,China)
出处 《中国血液净化》 CSCD 2020年第12期811-815,共5页 Chinese Journal of Blood Purification
基金 宁夏自治区重点研发项目(2018BEG030)。
关键词 腹膜透析 贫血 血红蛋白 Peritoneal dialysis Anemia Hemoglobin
  • 相关文献

参考文献8

二级参考文献76

  • 1缪世梅,徐学康,钱桐荪,魏迎凤,张小梅,王爱萍.大剂量重组人促红细胞生成素治疗肾性贫血20例[J].南通大学学报(医学版),2009,29(4):272-273. 被引量:4
  • 2北京市血液透析质量控制和改进中心.北京市血液透析登记2007年年度报告[R].北京:北京市血液透析质量控制和改进中心,2009.
  • 3KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease[J].Am J Kidney Dis,2006,47:S1-145.
  • 4Mathieu CM,Teta D,Lotscher N,et al.Optimal and continu-ons anaemia control in a cohort of dialysis patients in Switzerland[J].BMC Nephrol,2008,11:9-16.
  • 5Pisoni RL,Bragg-Gresham JL,Young EW,et al.Anemia manangement and outcomes from 12 countries in the dialysis outcomes and practice patttems study(DOPPS)[J].Am J Kid-ney Dis,2004:94-111.
  • 6Jacobs C,Frei D.Perkins AC.Result of the European Survey on Anaemia management 2003(ESAM 2003):Current status of anaemia management in dialysis patient,factors affecting epoetin dosage and changes in anaemia manangement over the last 5 years[J].Nephrol Dial Transplant,2005,20:iii3-iii24.
  • 7Port FK, Pisoni RL, Bragg-Gresham JL, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif,2004,22 ( 1 ) : 175 - 180.
  • 8Pisoni RL, Bragg-Gresham JL, Young EW, et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis ,20(M ,44 ( 1 ) :94 - 111.
  • 9KDOQI. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis ,2006,47 ( 5 Suppl 3 ) : S11 - 145.
  • 10Locatelli F, Conte F, Marcelli D. The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry. Nephrol Dial Transplant, 1998,13 (7) : 1642 - 1644.

共引文献316

同被引文献33

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部